Genome-wide DNA Methylation Events inTMPRSS2–ERGFusion-Negative Prostate Cancers Implicate an EZH2-Dependent Mechanism withmiR-26aHypermethylation-Reference-Cited by-同舟云学术

Genome-wide DNA Methylation Events inTMPRSS2–ERGFusion-Negative Prostate Cancers Implicate an EZH2-Dependent Mechanism withmiR-26aHypermethylation

Published:2012-08-28 Issue:11 Volume:2 Page:1024-1035
ISSN:2159-8274
Container-title:Cancer Discovery
language:en
Short-container-title:Cancer Discovery

Author:

Börno Stefan T.,Fischer Axel,Kerick Martin,Fälth Maria,Laible Mark,Brase Jan C.,Kuner Ruprecht,Dahl Andreas,Grimm Christina,Sayanjali Behnam,Isau Melanie,Röhr Christina,Wunderlich Andrea,Timmermann Bernd,Claus Rainer,Plass Christoph,Graefen Markus,Simon Ronald,Demichelis Francesca,Rubin Mark A.,Sauter Guido,Schlomm Thorsten,Sültmann Holger,Lehrach Hans,Schweiger Michal R.

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PLXNA1 confers enzalutamide resistance in prostate cancer via AKT signaling pathway;Neoplasia;2024-11

2. Prostate cancer subtyping and differential methylation analysis based on the ETS family of transcription factors fusion genes;Scientific Reports;2024-09-06

3. TP63–TRIM29 axis regulates enhancer methylation and chromosomal instability in prostate cancer;Epigenetics & Chromatin;2024-03-14

4. Germline Genetic Variants Associated with Somatic TMPRSS2:ERG Fusion Status in Prostate Cancer: A Genome-Wide Association Study;Cancer Epidemiology, Biomarkers & Prevention;2023-08-09

5. Characterization and evaluation of gene fusions as a measure of genetic instability and disease prognosis in prostate cancer;BMC Cancer;2023-06-22